Immunoassays

The PAPP-A enzyme linked immunosorbent assay (ELISA) kit provides materials for the quantitative measurement of PAPP-A in serum and other biological fluids. This assay is intended for in vitro diagnostic use.

COVELISA®COVID-19 IgM ELISA is an in-vitro semi-quantitative detection test of human antibodies of the immunoglobulin class IgM directed against SARS-CoV-2.

Der Varicella-Zoster Virus (VZV) IgA ELISA ist für den qualitativen Nachweis spezifischer IgA-Antikörper gegen Varicella-Zoster Virus (VZV) in humanem Serum oder Plasma (Citrat, Heparin) bestimmt.

This protocol details the procedure for testing samples with the OLM Aspergillus LFD (AspLFD). The following protocol is summarised in the figure overleaf. Please see the AspLFD handbook for more detailed product information.

Affimedixs Rapi-D Quantitative Vitamin D Test is an immunochromatography-based one step in vitro test.

real-time RT-PCR-based diagnostic test for the in vitro qualitative detection and discrimination of SARS-CoV-2, Delta and Omicron.

The PhoenixDx® SARS-CoV-2 Neutralizing Antibody Test Kit (ELISA) is used for the in vitro qualitative detection of neutralizing antibodies (nAb) against RBD of Novel Coronavirus (SARS-CoV-2) S1 protein in human serum or plasma.

The Avidity Epstein-Barr Virus (VCA) IgG ELISA is intended to indicate the Epstein-Barr virus viral capsid antigen (VCA)-specific IgG avidity in human serum or plasma (citrate, heparin) to differentiate between acute and past infection.

The Avidity Measles Virus IgG ELISA is intended to indicate the Measles-specific IgG avidity in human serum or plasma (citrate, heparin) to differentiate between acute and past infection.